All 65 XLV Holdings
XLV, the Health Care Select Sector SPDR Fund, tracks the performance of the Health Care Select Sector Index, providing exposure to the healthcare sector of the U.S. stock market. The fund comprises companies involved in industries such as pharmaceuticals, biotechnology, healthcare equipment and supplies, and healthcare providers and services. By investing in XLV, investors can gain diversified exposure to leading healthcare companies, benefiting from the sector's growth potential and defensive characteristics.
**Charts show 1 year
| Rank | Ticker | Company | Weight | Country | Market Cap | Industry |
|---|---|---|---|---|---|---|
| 1 | LLY |   | 11.1% | United States | $367b | Drug Manufacturers-General |
| 2 | UNH |  | 8.84% | United States | $459b | Healthcare Plans |
| 3 | JNJ |  | 7.51% | United States | $430b | Drug Manufacturers-General |
| 4 | MRK |  | 6.2% | United States | $296b | Drug Manufacturers-General |
| 5 | ABBV |  | 5.72% | United States | $292b | Drug Manufacturers-General |
| 6 | TMO |  | 4.14% | United States | $211b | Diagnostics & Research |
| 7 | ABT |  | 3.59% | United States | $191b | Medical Devices |
| 8 | DHR |  | 2.98% | United States | $169b | Diagnostics & Research |
| 9 | PFE |  | 2.84% | United States | $221b | Drug Manufacturers-General |
| 10 | AMGN |  | 2.8% | United States | $131b | Drug Manufacturers-General |
| 11 | ISRG |  | 2.49% | United States | $103b | Medical Instruments & Supplies |
| 12 | ELV |  | 2.45% | United States | $109b | Healthcare Plans |
| 13 | SYK |  | 2.13% | United States | $113b | Medical Devices |
| 14 | MDT |  | 2.06% | United States | $119b | Medical Devices |
| 15 | CI |  | 2.03% | United States | $75b | Healthcare Plans |
| 16 | BMY |  | 2.01% | United States | $147b | Drug Manufacturers-General |
| 17 | VRTX |  | 1.98% | United States | $85b | Biotechnology |
| 18 | BSX |  | 1.88% | United States | $73b | Medical Devices |
| 19 | REGN |  | 1.86% | United States | $85b | Biotechnology |
| 20 | CVS |  | 1.72% | United States | $94b | Healthcare Plans |
| 21 | GILD |  | 1.61% | United States | $107b | Drug Manufacturers-General |
| 22 | MCK |  | 1.39% | United States | $50b | Medical Distribution |
| 23 | ZTS |  | 1.31% | United States | $80b | Drug Manufacturers-Specialty & Generic |
| 24 | BDX |  | 1.28% | United States | $74b | Medical Instruments & Supplies |
| 25 | HCA |  | 1.27% | United States | $78b | Medical Care Facilities |
| 26 | L0T |  | 1.17% | Germany | Health Information Services | |
| 27 | EW |  | 1.03% | United States | $53b | Medical Devices |
| 28 | DXCM |  | 0.98% | United States | $48b | Medical Devices |
| 29 | IQV |  | 0.83% | United States | $36b | Diagnostics & Research |
| 30 | CNC |  | 0.8% | United States | $38b | Healthcare Plans |
| 31 | HUM |  | 0.78% | United States | $63b | Healthcare Plans |
| 32 | A |  | 0.76% | United States | $39b | Diagnostics & Research |
| 32 | IDXX |  | 0.76% | United States | $40b | Diagnostics & Research |
| 34 | MRNA |  | 0.66% | United States | $52b | Biotechnology |
| 35 | BIIB |  | 0.54% | United States | $41b | Drug Manufacturers-General |
| 36 | WST |  | 0.53% | United States | $26b | Medical Instruments & Supplies |
| 37 | CAH |  | 0.51% | United States | $21b | Medical Distribution |
| 37 | MTD |  | 0.51% | United States | $33b | Diagnostics & Research |
| 37 | RMD |  | 0.51% | United States | $33b | Medical Instruments & Supplies |
| 40 | ZBH |  | 0.49% | United States | $29b | Medical Devices |
| 41 | ALGN |  | 0.42% | United States | $27b | Medical Devices |
| 42 | MOH |  | 0.41% | United States | $16.17b | Healthcare Plans |
| 43 | BAX |  | 0.39% | United States | $23b | Medical Instruments & Supplies |
| 44 | STE |  | 0.38% | United States | $18.05b | Medical Devices |
| 45 | HOLX |  | 0.36% | United States | $21b | Medical Instruments & Supplies |
| 45 | ILMN |  | 0.36% | United States | $35b | Diagnostics & Research |
| 47 | LH |  | 0.35% | United States | $19.59b | Diagnostics & Research |
| 48 | WAT |  | 0.34% | United States | $17.25b | Diagnostics & Research |
| 49 | DGX |  | 0.28% | United States | $16.31b | Diagnostics & Research |
| 50 | PKI |  | 0.27% | United States | $16.12b | Diagnostics & Research |